Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Boehm Rainer J.
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Szela Mary T
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SCHADE CHRISTIAN S
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MENDLEIN JOHN
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Levy Elliott M.
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kender Richard N
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Werner Michelle C
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Young Richard A
Omega Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Kender Richard N
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Certel Kaan
Omega Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Certel Kaan
Omega Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Chan Barbara Y
Omega Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(10.678%),Abigail P. Johnson(10.678%)
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McCauley Thomas
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Karande Mahesh
Omega Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director SCHADE CHRISTIAN S
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SCHADE CHRISTIAN S
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reed Joshua
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Moore Yan
Omega Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zeng Ling
No Data